194 related articles for article (PubMed ID: 36648710)
1. Association between financial toxicity and health-related quality of life of patients with gynecologic cancer.
Kajimoto Y; Honda K; Suzuki S; Mori M; Tsubouchi H; Nakao K; Azuma A; Shibutani T; Nagao S; Koyanagi T; Kohara I; Tamaki S; Yabuki M; Teng L; Fujiwara K; Igarashi A
Int J Clin Oncol; 2023 Mar; 28(3):454-467. PubMed ID: 36648710
[TBL] [Abstract][Full Text] [Related]
2. Mapping EORTC QLQ-C30 and FACT-G onto EQ-5D-5L index for patients with cancer.
Hagiwara Y; Shiroiwa T; Taira N; Kawahara T; Konomura K; Noto S; Fukuda T; Shimozuma K
Health Qual Life Outcomes; 2020 Nov; 18(1):354. PubMed ID: 33143687
[TBL] [Abstract][Full Text] [Related]
3. Mapping EORTC-QLQ-C30 and QLQ-CR29 onto EQ-5D-5L in Colorectal Cancer Patients.
Ameri H; Yousefi M; Yaseri M; Nahvijou A; Arab M; Akbari Sari A
J Gastrointest Cancer; 2020 Mar; 51(1):196-203. PubMed ID: 30977049
[TBL] [Abstract][Full Text] [Related]
4. Reliability and validity of the Amharic version of European Organization for Research and Treatment of cervical Cancer module for the assessment of health related quality of life in women with cervical cancer in Addis Ababa, Ethiopia.
Araya LT; Gebretekle GB; Gebremariam GT; Fenta TG
Health Qual Life Outcomes; 2019 Jan; 17(1):13. PubMed ID: 30642359
[TBL] [Abstract][Full Text] [Related]
5. Financial toxicity in patients with gynecologic malignancies: a cross sectional study.
Zeybek B; Webster E; Pogosian N; Tymon-Rosario J; Balch A; Altwerger G; Clark M; Menderes G; Huang G; Azodi M; Ratner ES; Schwartz PE; Santin AD; Andikyan V
J Gynecol Oncol; 2021 Nov; 32(6):e87. PubMed ID: 34431257
[TBL] [Abstract][Full Text] [Related]
6. The European Organization for Research and Treatment of Cancer (EORTC) Quality-of-Life questionnaire cervical cancer module: EORTC QLQ-CX24.
Greimel ER; Kuljanic Vlasic K; Waldenstrom AC; Duric VM; Jensen PT; Singer S; Chie W; Nordin A; Bjelic Radisic V; Wydra D;
Cancer; 2006 Oct; 107(8):1812-22. PubMed ID: 16977652
[TBL] [Abstract][Full Text] [Related]
7. Mapping EORTC-QLQ-C30 to EQ-5D-3L in patients with colorectal cancer.
Marriott ER; van Hazel G; Gibbs P; Hatswell AJ
J Med Econ; 2017 Feb; 20(2):193-199. PubMed ID: 27676291
[TBL] [Abstract][Full Text] [Related]
8. Validation of Korean Version of the COmprehensive Score for financial Toxicity (COST) Among Breast Cancer Survivors.
Shim S; Kang D; Kim N; Han G; Lim J; Kim H; Park J; Lee M; Lee JE; Kim SW; Yu J; Chae BJ; Ryu JM; Nam SJ; Lee SK; Cho J
Cancer Res Treat; 2022 Jul; 54(3):834-841. PubMed ID: 34645130
[TBL] [Abstract][Full Text] [Related]
9. Assessing the validity of EQ-5D-5L in people with head & neck cancer: Does a generic quality of life measure perform as well as a disease-specific measure in a patient population?
Davies A; Waylen A; Leary S; Thomas S; Pring M; Janssen B; Beynon R; Lang S; Schimansky S; Hurley K; Ness A
Oral Oncol; 2020 Feb; 101():104504. PubMed ID: 31835074
[TBL] [Abstract][Full Text] [Related]
10. Assessing health-related quality of life in gynecologic oncology: a systematic review of questionnaires and their ability to detect clinically important differences and change.
Luckett T; King M; Butow P; Friedlander M; Paris T
Int J Gynecol Cancer; 2010 May; 20(4):664-84. PubMed ID: 20442592
[TBL] [Abstract][Full Text] [Related]
11. Impact of lower limb lymphedema on quality of life in gynecologic cancer survivors after pelvic lymph node dissection.
Kim SI; Lim MC; Lee JS; Lee Y; Park K; Joo J; Seo SS; Kang S; Chung SH; Park SY
Eur J Obstet Gynecol Reprod Biol; 2015 Sep; 192():31-6. PubMed ID: 26142914
[TBL] [Abstract][Full Text] [Related]
12. Quality of Life After Bladder Cancer: A Cross-sectional Survey of Patient-reported Outcomes.
Catto JWF; Downing A; Mason S; Wright P; Absolom K; Bottomley S; Hounsome L; Hussain S; Varughese M; Raw C; Kelly P; Glaser AW
Eur Urol; 2021 May; 79(5):621-632. PubMed ID: 33581875
[TBL] [Abstract][Full Text] [Related]
13. Which Questionnaire Should Be Used to Measure Quality-of-Life Utilities in Patients with Acute Leukemia? An Evaluation of the Validity and Interpretability of the EQ-5D-5L and Preference-Based Questionnaires Derived from the EORTC QLQ-C30.
van Dongen-Leunis A; Redekop WK; Uyl-de Groot CA
Value Health; 2016; 19(6):834-843. PubMed ID: 27712712
[TBL] [Abstract][Full Text] [Related]
14. Financial toxicity in gynecologic oncology.
Bouberhan S; Shea M; Kennedy A; Erlinger A; Stack-Dunnbier H; Buss MK; Moss L; Nolan K; Awtrey C; Dalrymple JL; Garrett L; Liu FW; Hacker MR; Esselen KM
Gynecol Oncol; 2019 Jul; 154(1):8-12. PubMed ID: 31053404
[TBL] [Abstract][Full Text] [Related]
15. Feasibility of implementing a cervix cancer-specific patient-reported outcome measure in routine ambulatory clinics.
Atallah S; Barbera L; Folwell M; Howell D; Liu Z; Croke J
Support Care Cancer; 2021 Jan; 29(1):499-507. PubMed ID: 32405964
[TBL] [Abstract][Full Text] [Related]
16. Mapping the cancer-specific QLQ-C30 onto the generic EQ-5D-5L and SF-6D in colorectal cancer patients.
Ameri H; Yousefi M; Yaseri M; Nahvijou A; Arab M; Akbari Sari A
Expert Rev Pharmacoecon Outcomes Res; 2019 Feb; 19(1):89-96. PubMed ID: 30173585
[TBL] [Abstract][Full Text] [Related]
17. Crowdsourcing to measure financial toxicity in gynecologic oncology.
Esselen KM; Stack-Dunnbier H; Gompers A; Hacker MR
Gynecol Oncol; 2021 May; 161(2):595-600. PubMed ID: 33551197
[TBL] [Abstract][Full Text] [Related]
18. Quality of life of caregivers of breast cancer patients: a cross-sectional evaluation.
Clarijs ME; Oemrawsingh A; Bröker MEE; Verhoef C; Lingsma H; Koppert LB
Health Qual Life Outcomes; 2022 Feb; 20(1):29. PubMed ID: 35183212
[TBL] [Abstract][Full Text] [Related]
19. Mapping EORTC QLQ-C30 and QLQ-MY20 to EQ-5D in patients with multiple myeloma.
Proskorovsky I; Lewis P; Williams CD; Jordan K; Kyriakou C; Ishak J; Davies FE
Health Qual Life Outcomes; 2014 Mar; 12():35. PubMed ID: 24618388
[TBL] [Abstract][Full Text] [Related]
20. Association of financial toxicity with quality of life in testicular cancer survivors.
Nezu K; Yamashita S; Kakimoto K; Uemura M; Kishida T; Kawai K; Nakamura T; Goto T; Osawa T; Nishimura K; Nonomura N; Negoro H; Shiraishi T; Ukimura O; Ogawa O; Shinohara N; Suzukamo Y; Ito A; Arai Y
Int J Urol; 2022 Dec; 29(12):1526-1534. PubMed ID: 36102302
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
